Access to advanced treatment and education is imperative in a world where hundreds of thousands are affected by bleeding and clotting disorders. Over the years, the International Society on Thrombosis and Haemostasis (ISTH) and the World Federation of Hemophilia (WFH) fellowship programs have provided healthcare professionals around the world with education to advance the treatment of patients with these conditions. Now, with support from Bayer HealthCare, these two organizations will come together to host an inaugural joint fellowship event at the ISTH 2015 Congress entitled “Building Capacity and Empowering Future Leaders” on Sunday, June 21, from 13:00 to 15:00 (1-3 p.m.) in room 715 of the Metro Toronto Convention Centre.

Reaching-the-WorldOpen to all attendees of the ISTH 2015 Congress, the event aims to raise awareness of the need for leadership development and capacity building in the fields of hemophilia, hematology and thrombosis. It will feature alumni from WFH’s International Hemophilia Training Center (IHTC) Fellowship Program and ISTH’s Reach-the-World program.

With Bayer sponsorship, the ISTH and WFH have helped nearly 500 fellows, mentors and future leaders gain the expertise and leadership development training needed to advance hemophilia, hematology and thrombosis care globally.

The International Hemophilia Treatment Center (IHTC) Fellowship, WFH’s longest-running program, awards up to 35 fellowships to medical and paramedical staff each year, allowing them to participate in a four- to six-week training program in hemophilia management at one of the designated Hemophilia Treatment Centers around the word.

“The IHTC fellowship is one of WFH’s flagship programs,” said Alan Weill, WFH president. “Our mission is to further the treatment of hemophilia and other inherited bleeding disorders through education, which would not be possible without the continued commitment and support of Bayer, who see the value in cultivating leaders in the field.”

The ISTH Reach-the-World program provides young healthcare professionals from developing countries with the opportunity to participate in a global exchange, while gaining knowledge and education related to thrombosis and hemostasis.

“As the leading international thrombosis and hemostasis society, the ISTH has a long history of providing support to healthcare professionals,” said Nigel Key, M.D., ISTH council chairman. “Showcasing our efforts, in collaboration with WFH and Bayer will further increase the interest and impact of these important programs.”


By |June 9, 2015